Clinical management of Parkinson's disease dementia: Pitfalls and progress

Michael Samuel, Ian Maidment, Malaz Boustani, Chris Fox

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

The non-motor symptoms of Parkinson's disease, which include cognitive, behavioural and psychological problems, are significant not just in epidemiological terms but also in their impact on patients and carers. Each symptom requires careful evaluation, owing to the potential overlap with comorbid conditions and also to the multiple aetiological pathways in Parkinson's disease. Such monitoring allows enhanced management. However, the diagnostic difficulties arising from these non-motor symptoms require further research. Here we describe the efficacy and some of the problems of medication used for non-motor symptoms, including antiparkinsonian medication, antipsychotics and acetylcholinesterase inhibitors.

Original languageEnglish (US)
Pages (from-to)121-129
Number of pages9
JournalAdvances in Psychiatric Treatment
Volume12
Issue number2
DOIs
StatePublished - Mar 2006
Externally publishedYes

Fingerprint

Parkinson Disease
Dementia
Antiparkinson Agents
Cholinesterase Inhibitors
Caregivers
Antipsychotic Agents
Psychology
Research
Problem Behavior

ASJC Scopus subject areas

  • Psychiatry and Mental health

Cite this

Clinical management of Parkinson's disease dementia : Pitfalls and progress. / Samuel, Michael; Maidment, Ian; Boustani, Malaz; Fox, Chris.

In: Advances in Psychiatric Treatment, Vol. 12, No. 2, 03.2006, p. 121-129.

Research output: Contribution to journalArticle

Samuel, Michael ; Maidment, Ian ; Boustani, Malaz ; Fox, Chris. / Clinical management of Parkinson's disease dementia : Pitfalls and progress. In: Advances in Psychiatric Treatment. 2006 ; Vol. 12, No. 2. pp. 121-129.
@article{354d9c56858f4f2dae533a41aab37246,
title = "Clinical management of Parkinson's disease dementia: Pitfalls and progress",
abstract = "The non-motor symptoms of Parkinson's disease, which include cognitive, behavioural and psychological problems, are significant not just in epidemiological terms but also in their impact on patients and carers. Each symptom requires careful evaluation, owing to the potential overlap with comorbid conditions and also to the multiple aetiological pathways in Parkinson's disease. Such monitoring allows enhanced management. However, the diagnostic difficulties arising from these non-motor symptoms require further research. Here we describe the efficacy and some of the problems of medication used for non-motor symptoms, including antiparkinsonian medication, antipsychotics and acetylcholinesterase inhibitors.",
author = "Michael Samuel and Ian Maidment and Malaz Boustani and Chris Fox",
year = "2006",
month = "3",
doi = "10.1192/apt.12.2.121",
language = "English (US)",
volume = "12",
pages = "121--129",
journal = "Advances in Psychiatric Treatment",
issn = "1355-5146",
publisher = "Royal College of Psychiatrists",
number = "2",

}

TY - JOUR

T1 - Clinical management of Parkinson's disease dementia

T2 - Pitfalls and progress

AU - Samuel, Michael

AU - Maidment, Ian

AU - Boustani, Malaz

AU - Fox, Chris

PY - 2006/3

Y1 - 2006/3

N2 - The non-motor symptoms of Parkinson's disease, which include cognitive, behavioural and psychological problems, are significant not just in epidemiological terms but also in their impact on patients and carers. Each symptom requires careful evaluation, owing to the potential overlap with comorbid conditions and also to the multiple aetiological pathways in Parkinson's disease. Such monitoring allows enhanced management. However, the diagnostic difficulties arising from these non-motor symptoms require further research. Here we describe the efficacy and some of the problems of medication used for non-motor symptoms, including antiparkinsonian medication, antipsychotics and acetylcholinesterase inhibitors.

AB - The non-motor symptoms of Parkinson's disease, which include cognitive, behavioural and psychological problems, are significant not just in epidemiological terms but also in their impact on patients and carers. Each symptom requires careful evaluation, owing to the potential overlap with comorbid conditions and also to the multiple aetiological pathways in Parkinson's disease. Such monitoring allows enhanced management. However, the diagnostic difficulties arising from these non-motor symptoms require further research. Here we describe the efficacy and some of the problems of medication used for non-motor symptoms, including antiparkinsonian medication, antipsychotics and acetylcholinesterase inhibitors.

UR - http://www.scopus.com/inward/record.url?scp=33644782515&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33644782515&partnerID=8YFLogxK

U2 - 10.1192/apt.12.2.121

DO - 10.1192/apt.12.2.121

M3 - Article

AN - SCOPUS:33644782515

VL - 12

SP - 121

EP - 129

JO - Advances in Psychiatric Treatment

JF - Advances in Psychiatric Treatment

SN - 1355-5146

IS - 2

ER -